According to Aurobindo Pharma 's latest financial reports the company's total liabilities are HK$15.74 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-03-31 | HK$14.28 B | 14.69% |
2023-03-31 | HK$12.45 B | 29.14% |
2022-03-31 | HK$9.64 B | -23.83% |
2021-03-31 | HK$12.66 B | 1.68% |
2020-03-31 | HK$12.45 B | -12.3% |
2019-03-31 | HK$14.20 B | 25.08% |
2018-03-31 | HK$11.35 B | 37.84% |
2017-03-31 | HK$8.23 B | -22.7% |
2016-03-31 | HK$10.65 B | 15.27% |
2015-03-31 | HK$9.24 B | 25.14% |
2014-03-31 | HK$7.38 B | 10.94% |
2013-03-31 | HK$6.65 B | 12.17% |
2012-03-31 | HK$5.93 B | -0.75% |
2011-03-31 | HK$5.98 B | 16.14% |
2010-03-31 | HK$5.15 B | 12.65% |
2009-03-31 | HK$4.57 B | -6.08% |
2008-03-31 | HK$4.86 B | 2.8% |
2007-03-31 | HK$4.73 B | 45.21% |
2006-03-31 | HK$3.26 B | 28.55% |
2005-03-31 | HK$2.53 B | 23.87% |
2004-03-31 | HK$2.04 B |